Cargando…
Synergistic Effects of PPARγ Ligands and Retinoids in Cancer Treatment
Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptor superfamily. The activation of PPARs by their specific ligands is regarded as one of the promising strategies to inhibit cancer cell growth. However, recent clinical trials targeting several common cancers showed...
Autores principales: | Shimizu, Masahito, Moriwaki, Hisataka |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408709/ https://www.ncbi.nlm.nih.gov/pubmed/18528526 http://dx.doi.org/10.1155/2008/181047 |
Ejemplares similares
-
Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis
por: Shimizu, Masahito, et al.
Publicado: (2012) -
Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells
por: Baba, Atsushi, et al.
Publicado: (2013) -
The Effect of Acyclic Retinoid on the Metabolomic Profiles of Hepatocytes and Hepatocellular Carcinoma Cells
por: Qin, Xian-Yang, et al.
Publicado: (2013) -
Effects of PPARγ Ligands on Leukemia
por: Tabe, Yoko, et al.
Publicado: (2012) -
Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)